Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Cempra Presents Data on Ophthalmic Solithromycin at ARVO

CEMPRA (CEMP) 
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
Company Research Source: GlobeNewswire
CHAPEL HILL, N.C., May 10, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the company is presenting two abstracts highlighting topical ophthalmic formulations of solithromycin in preclinical models of activity, tolerability and pharmacokinetics (PK) in the eye at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Baltimore, MD. In one study, several formulations of 1% solithromycin ophthalmic solution were developed and screened in preclinical models to assess tolerability, and to evaluate achievement of desired PK parameters for an ophthalmic solution.  Researchers found solithromycin ophthalmic solution to achieve appropriate concentrations in ocular and periocular tissues, and to be well tolerated with no signs of ocular redness, discomfort or irritation. Clinically Show less Read more
Impact Snapshot
Event Time:
CEMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CEMP alerts
Opt-in for
CEMP alerts

from News Quantified
Opt-in for
CEMP alerts

from News Quantified